Covalent inhibitors of the GTPase KRASG12C: a review of the patent literature
{{output}}
Introduction: KRAS is one of the most important oncology drug targets, playing a pivotal role in the initiation and progression of many human tumors. It has long been held undruggable due to many previously failed attempts to both directly and indirectly targe... ...